|Bid||68.97 x 800|
|Ask||68.98 x 800|
|Day's Range||67.55 - 69.34|
|52 Week Range||43.11 - 72.61|
|Beta (5Y Monthly)||1.31|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 02, 2021 - Aug 06, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||73.50|
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the appointment of Juliet C. Cunningham as the vice president of Investor Relations, effective immediately. In this role, Ms. Cunningham is responsible for the Company's investor relations program and reports directly to Chief Financial Officer Matt Harbaugh.
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
NuVasive's (NUVA) first-quarter revenues improved year over year led by progress in U.S. procedural volumes and international business.